• Welcome to the Center for Molecular Imaging.
    Welcome to the Center for Molecular Imaging.
    The major focus of the CMI is the development of imaging technology and contrast agents to see human disease at its earliest possible manifestation.
  • We believe that Seeing is Curing.™
    We believe that Seeing is Curing.™
    If a disease can be seen, it can be diagnosed and treated—and there is a greater likelihood of finding a cure.
  • Our focus is Bench-to-Bedside medicine.
    Our focus is Bench-to-Bedside medicine.
    Scientific theory needs to move from the laboratory bench to the patient’s beside to be beneficial—our focus is on development of practical clinical solutions.
  • Collaboration brings us closer to the cure.
    Collaboration brings us closer to the cure.
    Working with a team of local, national, and international collaborators, we freely share ideas and data to move closer to a cure for human diseases.
  • The future is Personalized Medicine.
    The future is Personalized Medicine.
    We are developing the next generation of imaging technology to permit medical decisions based on the individual needs of the patient.

Our Mission

Our mission is to solve important clinical problems by applying first principles from chemistry and engineering.

We believe that Seeing is Curing - that is, if we can see cancer at an earlier stage than we now can (currently about 1 billion cells) we will have a greater likelihood of curing it.

Molecular Images

Seeing is Curing

A. LAM tumor in the lung with hematoxylin and
    eosin (H&E) staining
B. PET/CT using F-18-FDG
C. Thyroid uptake of pertechnetate by SPECT/CT
D. Prostate cancer with H&E staining

  • Featured News

Take a Virtual Tour!

Our lab video includes interviews with key collaborators and researchers and provides an overview of the important work happening at the Center for Molecular Imaging.


3/4/2013

We are pleased to announce that Sylvain Gioux, Ph.D., director of the Biomedical Optics and Engineering Laboratory, has been promoted to the rank of Assistant Professor of Medicine at Harvard Medical School.


1/10/2013

The Joint International Oncology Congress, to be held in San Francisco May 27-29, 2013, is now open for registration. Click here for more information.


5/4/2012

Postdoctoral Researcher Vivek Venugopal, Ph.D. wins the Karen and Lester Gerhardt Prize in Science and Engineering and the Zelda and David G. Gisser Prize in Biomedical Engineering from Rensselaer Polytechnic Institute for his doctoral dissertation.